Horizon Kinetics Medical ETF
MEDX
Market cap $13M

27.10 USD

-0.17

0.62%

At close Jun 13, 4:00 PM EDT

1 day

-0.62%

5 days

1.23%

1 month

6.90%

3 months

-3.11%

6 months

-0.95%

Year to date

3.04%

1 year

-9.06%

5 years

-13.28%

10 years

-13.28%

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

20% more capital invested

Capital invested by funds: $432K [Q4 2024] → $518K (+$86K) [Q1 2025]

0.48% more ownership

Funds ownership: 3.59% [Q4 2024] → 4.07% (+0.48%) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

43% less funds holding

Funds holding: 7 [Q4 2024] → 4 (-3) [Q1 2025]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MEDX.

See Analyst Rankings

Financial journalist opinion

Positive

Zacks Investment Research

1 year ago

ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook

Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.